Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women

East Mediterr Health J. 2009 Jan-Feb;15(1):94-103.

Abstract

During the mass measles/rubella vaccination campaign in 2003 in Iran, many pregnant women were vaccinated mistakenly or became pregnant within 1 month of vaccination. To distinguish pregnant women who were affected by rubella vaccine as primary infection from those who had rubella reinfection from the vaccine, serum samples were collected 1-3 months after the campaign from 812 pregnant women. IgG avidity assay showed that 0.3% of the women had no rubella-specific IgG response; 14.4% had low-avidity anti-rubella IgG and were therefore not immune to rubella before vaccination; 85.3% had high-avidity anti-rubella IgG and were regarded as cases of reinfection.

Publication types

  • Validation Study

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology*
  • Antibody Affinity / immunology
  • Chi-Square Distribution
  • Female
  • Humans
  • Immunoenzyme Techniques / methods*
  • Immunoenzyme Techniques / standards
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology*
  • Iran / epidemiology
  • Mass Vaccination / adverse effects
  • Mass Vaccination / methods
  • Medical Errors / statistics & numerical data
  • Predictive Value of Tests
  • Pregnancy
  • Pregnancy Complications, Infectious / blood
  • Pregnancy Complications, Infectious / epidemiology*
  • Pregnancy Complications, Infectious / immunology
  • Pregnancy Complications, Infectious / virology
  • Rubella / blood
  • Rubella / epidemiology*
  • Rubella / immunology
  • Rubella / virology
  • Rubella Vaccine / adverse effects*
  • Rubella Vaccine / immunology
  • Rubella virus / immunology*
  • Seroepidemiologic Studies
  • Statistics, Nonparametric

Substances

  • Antibodies, Viral
  • Immunoglobulin G
  • Rubella Vaccine